This inventor holds 1 USPTO granted patent. Top assignee: Huazhong University of Science and Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Xingwei Zhao in Hematoma Aspiration Decision-Making
Introduction
Xingwei Zhao is an accomplished inventor based in Wuhan, China. He has made significant contributions to the field of medical technology, particularly in the area of intracerebral hemorrhage treatment. His innovative approach focuses on improving the decision-making process for hematoma aspiration procedures.
Latest Patents
Xingwei Zhao holds a patent for a "Processing method and device of hematoma aspiration decision-making system for intracerebral hemorrhage." This invention introduces a two-layer deep neural network designed to enhance the processing of hematoma aspiration protocols. The system overcomes the unpredictability of results associated with traditional methods. It provides direct and convenient information transmission for surgeons, thereby improving the accuracy of aspiration treatment protocols for intracerebral hematoma. This innovation offers digital, intelligent, and powerful support for clinical hematoma aspiration treatments.
Career Highlights
Xingwei Zhao is affiliated with Huazhong University of Science and Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential to significantly impact clinical practices in neurosurgery.
Collaborations
Xingwei Zhao collaborates with notable colleagues, including Zhouping Tang and Jian Shi. Their combined expertise contributes to the development of cutting-edge solutions in medical technology.
Conclusion
Xingwei Zhao's innovative contributions to the field of hematoma aspiration decision-making exemplify the intersection of technology and medicine. His work not only enhances surgical accuracy but also supports the advancement of clinical practices in treating intracerebral hemorrhage.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile